Strata Critical Medical (SRTA) Accounts Payables (2019 - 2026)

Strata Critical Medical has disclosed Accounts Payables across 8 years of filings, most recently posting $20.0 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 89.96% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $20.0 million (up 89.96% YoY), while the FY2025 annual figure was $19.1 million, up 107.61% from the prior year.
• Accounts Payables advanced to $20.0 million in Q1 2026, from $19.1 million in the prior quarter.
• Over the last five years, Accounts Payables for SRTA reached as high as $27.2 million in Q3 2025 and fell as low as $7.6 million in Q2 2022.
• The 5-year median for Accounts Payables is $14.9 million (2023), against an average of $15.1 million.
• Annual changes were most pronounced in 2022 — Accounts Payables soared 589.67% — and 2024, when it plunged 61.36%.
• A 5-year view of Accounts Payables shows it stood at $16.5 million in 2022, then soared by 44.29% to $23.9 million in 2023, then sank by 61.36% to $9.2 million in 2024, then surged by 107.61% to $19.1 million in 2025, then grew by 4.25% to $20.0 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $20.0 million, $19.1 million, and $27.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.